What Mounjaro does to the body, step by step

Step 1: the injection site and what happens in the first hours

After you inject tirzepatide under the skin (abdomen, thigh or upper arm) it is absorbed slowly into the bloodstream over the following hours. This steady absorption is deliberate. A rapid spike would produce stronger nausea; the gradual rise is why the medicine is dosed once a week rather than daily. Treatment begins at 2.5mg, a dose calibrated to let your system adjust rather than produce immediate therapeutic weight loss. Most people find the first four weeks relatively settled; noticeable appetite changes tend to build as doses increase over subsequent months.

Once circulating, tirzepatide binds to GIP receptors and GLP-1 receptors on cells across several organs. That dual binding is what sets tirzepatide apart from earlier GLP-1-only medicines. The NHS explains the mechanism in plain terms on its tirzepatide medicines page.

Step 2: what the gut and pancreas do differently

In the gut, activated GLP-1 receptors slow gastric emptying, the rate at which the stomach pushes food into the small intestine. Slower emptying means glucose enters the bloodstream more gradually after a meal, reducing the sharp spike that prompts a large insulin response. Separately, both GIP and GLP-1 receptors on the pancreas stimulate insulin release in a glucose-dependent way: the signal only fires when blood sugar is actually elevated, which is why tirzepatide carries a low standalone risk of hypoglycaemia in people without diabetes.

Cholecystokinin and other satiety peptides also rise in response to slower gastric emptying, reinforcing the fullness signal. The practical result for most people is that a smaller portion of food produces the same sense of satisfaction a larger meal used to. That is not a side effect, it is the mechanism working as intended. If you are curious about how this compares across different dose levels, the Mounjaro treatment overview covers what the evidence shows at each stage.

Step 3: the brain's role in appetite and reward

GLP-1 receptors exist in the hypothalamus and other appetite-regulating regions of the brain, not only in the gut. When tirzepatide activates them, the hypothalamus receives a sustained fullness signal even between meals. Food cravings (particularly for high-calorie, highly palatable foods) tend to become less insistent. Many people describe this as the mental noise around food quietening rather than willpower suddenly improving. Researchers are still mapping exactly how much of the appetite effect is central (brain-driven) versus peripheral (gut-driven); the neurological side of tirzepatide's action is a topic our team covers separately.

Some people on Mounjaro also notice mood changes, notably a reduction in food preoccupation. This is an active area of research. What is clear from SURMOUNT-1 (published in the New England Journal of Medicine and underpinning NICE's recommendation of tirzepatide (TA1026)) is that the combined effect on appetite, gut emptying and blood-sugar regulation produces average weight reductions that earlier single-pathway medicines did not reach.

What changes in the body over weeks and months of treatment

The effects described above accumulate. In the first few weeks, most of the change people notice is in appetite and portion size. By weeks eight to twelve, as doses typically increase, the rate of weight loss often becomes more visible on the scales. A practical habit worth building early: weigh yourself once a week, same time, same conditions, morning, after the bathroom, before eating. A consistent measurement tells you far more than daily fluctuations, and it gives our prescribers useful data if your dose is being reviewed.

Over months, reduced body weight itself changes how organs function. Blood pressure, cholesterol and blood-sugar markers often improve alongside weight loss, which is why weight-related conditions (hypertension, dyslipidaemia, obstructive sleep apnoea and others) form part of the eligibility criteria for treatment. The body does not become immune to the medicine in the way it might to a stimulant, though the rate of weight loss typically slows as a new, lower set-point is approached. There is more on whether the body adapts to Mounjaro over time if that question is on your mind.

Side effects, when they occur, are mostly gastrointestinal: nausea, loose stools, constipation, indigestion or burping. These are most common after starting or after a dose increase and usually settle within a week or two. Dizziness on standing is a less-discussed but real experience for some people, there is a specific explanation for why Mounjaro can cause dizziness when you stand that is worth reading if it happens to you.

Because Mounjaro is a prescription-only medicine, every dose decision is made by a prescriber who reviews your full picture, not a checklist. If you want to understand whether treatment might be appropriate for you, the cost context and what private treatment involves is a useful read before starting, and checking your eligibility takes only a few minutes with our clinical team.